| |
|
|
CRESCENT HEALTHCARE
OVERVIEW
Crescent Healthcare is a leading provider of specialty infusion and injectable pharmacy services.
www.crescenthealthcare.com
CEO1ST PARTNER(S)
Bob Funari, Chairman and CEO, is the former CEO of Syncor International, a publicly-traded radiopharmacy services company. He built the company from $250 million to over $750 million before spearheading its sale to Cardinal Health (NYSE: CAH). He also spent seventeen years with Baxter International (NYSE: BAX).
|
|
STATUS
Acquired majority ownership in company from owner-operator founder in 2004
Specialty pharmacy services is a $20+ billion market
A robust pipeline of bioengineered products is expected to fuel 20% annual growth, making this one of the fastest-growing sectors of healthcare
|